Alkermes - 29 Year Stock Price History | ALKS

Historical daily share price chart and data for Alkermes since 1991 adjusted for splits. The latest closing stock price for Alkermes as of October 20, 2020 is 16.92.
  • The all-time high Alkermes stock closing price was 98.05 on March 01, 2000.
  • The Alkermes 52-week high stock price is 21.88, which is 29.3% above the current share price.
  • The Alkermes 52-week low stock price is 11.98, which is 29.2% below the current share price.
  • The average Alkermes stock price for the last 52 weeks is 17.96.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Alkermes Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 17.3771 19.7600 21.2400 13.0600 16.9200 -17.06%
2019 25.4200 29.1100 37.3300 17.2900 20.4000 -30.87%
2018 45.9911 55.2200 67.2600 27.9400 29.5100 -46.08%
2017 54.8201 56.1000 61.6600 47.6900 54.7300 -1.53%
2016 45.4797 74.8300 75.2700 29.0500 55.5800 -29.98%
2015 66.3880 58.2400 80.1400 55.0800 79.3800 35.55%
2014 47.3686 40.2400 58.8800 40.0700 58.5600 44.02%
2013 30.2678 19.2800 41.1200 19.2800 40.6600 119.55%
2012 18.1842 17.3400 20.8800 15.1200 18.5200 6.68%
2011 15.4301 12.5500 19.5200 12.1400 17.3600 41.37%
2010 12.4457 9.7100 15.9200 9.6900 12.2800 30.50%
2009 9.6079 10.7100 13.1300 7.5600 9.4100 -11.64%
2008 12.2140 15.1000 16.8900 6.1000 10.6500 -31.69%
2007 15.7875 13.0900 18.5600 12.7600 15.5900 16.60%
2006 18.9792 20.5200 26.7100 13.1800 13.3700 -30.07%
2005 14.4015 14.0100 19.6600 10.0100 19.1200 35.70%
2004 13.3925 13.9700 16.8600 8.5100 14.0900 4.37%
2003 11.0874 6.6600 15.5600 6.5200 13.5000 115.31%
2002 15.1033 25.7500 30.3400 3.7800 6.2700 -76.21%
2001 26.8799 27.6300 37.1000 17.5000 26.3600 -16.00%
2000 41.5542 25.5000 98.0500 23.6250 31.3800 27.74%
1999 15.7511 11.6900 26.8150 11.4400 24.5650 121.41%
1998 9.9991 9.9400 13.3750 5.3150 11.0950 11.62%
1997 9.5169 11.1900 14.6900 5.1900 9.9400 -14.49%
1996 6.2174 3.7500 12.1250 3.7500 11.6250 192.89%
1995 2.4000 1.0315 4.3125 1.0000 3.9690 273.55%
1994 2.4714 3.6875 4.5000 1.0625 1.0625 -69.64%
1993 4.1401 4.5000 5.5000 3.1250 3.5000 -17.65%
1992 6.0673 9.0000 14.1900 2.7500 4.2500 -52.78%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.724B $1.171B
Alkermes, Inc. is a biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease. Alkermes currently has two commercial products: RISPERDAL CONSTA, the first and only long-acting atypical antipsychotic medication approved for use in schizophrenia, and marketed worldwide by Janssen-Cilag, a wholly owned division of Johnson & Johnson; and VIVITROL the first and only once-monthly injectable medication approved for the treatment of alcohol dependence and marketed in the U.S. primarily by Cephalon, Inc. Alkermes' pipeline includes extended-release injectable, pulmonary, and oral products for the treatment of prevalent, chronic diseases such as central nervous system disorders, addiction and diabetes.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $138.567B 10.67
Amgen (AMGN) United States $138.060B 14.99
CSL (CSLLY) Australia $97.403B 0.00
Gilead Sciences (GILD) United States $77.731B 11.19
Regeneron Pharmaceuticals (REGN) United States $63.808B 24.40
Vertex Pharmaceuticals (VRTX) United States $56.803B 31.70
Illumina (ILMN) United States $47.641B 55.40
Biogen (BIIB) United States $44.329B 7.59
Seattle Genetics (SGEN) United States $34.961B 0.00
Moderna (MRNA) United States $29.176B 0.00
BeiGene (BGNE) Cayman Islands $28.695B 0.00
Alexion Pharmaceuticals (ALXN) United States $27.206B 11.34
Genmab (GMAB) Denmark $24.097B 15.20
Genmab (GNMSF) Denmark $22.720B 5.23
BioNTech SE (BNTX) Germany $21.289B 0.00
Immunomedics (IMMU) United States $20.239B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.827B 0.00
Incyte (INCY) United States $19.821B 0.00
Alnylam Pharmaceuticals (ALNY) United States $16.862B 0.00
Horizon Therapeutics Public (HZNP) Ireland $16.440B 38.47
Bio-Rad Laboratories (BIO.B) United States $15.730B 71.14
Exact Sciences (EXAS) United States $15.515B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.372B 104.28
ARGENX SE-ADR (ARGX) Netherlands $12.687B 0.00
QIAGEN (QGEN) Netherlands $11.916B 30.24
MyoKardia (MYOK) United States $11.767B 0.00
Sarepta Therapeutics (SRPT) United States $11.181B 0.00
Bio-Techne Corp (TECH) United States $10.243B 70.28
Guardant Health (GH) United States $10.042B 0.00
Repligen (RGEN) United States $8.966B 142.31
Mirati Therapeutics (MRTX) United States $8.847B 0.00
Galapagos (GLPG) Belgium $8.418B 30.46
Ascendis Pharma (ASND) Denmark $8.374B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $7.707B 238.76
Exelixis (EXEL) United States $7.178B 26.10
Adaptive Biotechnologies (ADPT) United States $7.019B 0.00
Acceleron Pharma (XLRN) United States $6.997B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.719B 0.00
Novavax (NVAX) United States $6.559B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.832B 15.93
Blueprint Medicines (BPMC) United States $5.656B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.572B 0.00
Emergent Biosolutions (EBS) United States $5.233B 20.73
Vir Biotechnology (VIR) United States $5.011B 0.00
NeoGenomics (NEO) United States $4.770B 1439.67
Denali Therapeutics (DNLI) United States $4.679B 0.00
Arena Pharmaceuticals (ARNA) United States $4.665B 0.00
China Biologic Products (CBPO) China $4.479B 26.59
Amicus Therapeutics (FOLD) United States $4.443B 0.00
Twist Bioscience (TWST) United States $4.239B 0.00
Fate Therapeutics (FATE) United States $4.224B 0.00
Halozyme Therapeutics (HALO) United States $3.940B 0.00
Global Blood Therapeutics (GBT) United States $3.860B 0.00
Reata Pharmaceuticals (RETA) United States $3.790B 0.00
Bluebird Bio (BLUE) United States $3.715B 0.00
MorphoSys AG (MOR) Germany $3.688B 48.33
Insmed (INSM) United States $3.684B 0.00
Legend Biotech (LEGN) United States $3.632B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.321B 0.00
Eidos Therapeutics (EIDX) United States $2.938B 0.00
PHARMA MAR SA (PHMMF) Spain $2.876B 0.00
Seres Therapeutics (MCRB) United States $2.597B 0.00
Sorrento Therapeutics (SRNE) United States $2.434B 0.00
I-Mab (IMAB) China $2.319B 0.00
Zymeworks (ZYME) Canada $2.097B 0.00
Editas Medicine (EDIT) United States $2.096B 0.00
Forma Therapeutics Holdings (FMTX) United States $2.054B 0.00
Amarin (AMRN) Ireland $2.014B 0.00
Inovio Pharmaceuticals (INO) United States $1.985B 0.00
Viela Bio (VIE) United States $1.831B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.817B 20.35
Intra-Cellular Therapies (ITCI) United States $1.773B 0.00
Revance Therapeutics (RVNC) United States $1.689B 0.00
Beam Therapeutics (BEAM) United States $1.687B 0.00
Zealand Pharma (ZEAL) Denmark $1.597B 0.00
UniQure (QURE) Netherlands $1.589B 0.00
Sangamo Therapeutics (SGMO) United States $1.571B 0.00
Ligand Pharmaceuticals (LGND) United States $1.565B 52.89
Intellia Therapeutics (NTLA) United States $1.534B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.522B 0.00
Zealand Pharma (ZLDPF) Denmark $1.483B 0.00
Arcus Biosciences (RCUS) United States $1.364B 0.00
Epizyme (EPZM) United States $1.358B 0.00
Alcobra (ARCT) United States $1.349B 0.00
Coherus BioSciences (CHRS) United States $1.297B 7.56
Mesoblast (MESO) Australia $1.279B 0.00
Northwest Biotherapeutics (NWBO) United States $1.238B 0.00
Mersana Therapeutics (MRSN) United States $1.223B 0.00
Cytokineticsorporated (CYTK) United States $1.161B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.148B 0.00
NGM Biopharmaceuticals (NGM) United States $1.136B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.124B 0.00
Retrophin (RTRX) United States $1.114B 0.00
Compugen (CGEN) Israel $1.082B 0.00
REGENXBIO (RGNX) United States $1.073B 0.00
Genetron Holdings (GTH) China $1.042B 0.00
Athenex (ATNX) United States $1.022B 0.00
NantKwest (NK) United States $0.995B 0.00
Adverum Biotechnologies (ADVM) United States $0.995B 0.00
Heska (HSKA) United States $0.992B 0.00
Castle Biosciences (CSTL) United States $0.984B 0.00
Myriad Genetics (MYGN) United States $0.967B 0.00
Arvinas (ARVN) United States $0.937B 0.00
Vericel (VCEL) United States $0.936B 0.00
Pliant Therapeutics (PLRX) United States $0.881B 0.00
Intrexon (PGEN) United States $0.863B 0.00
Morphic Holding (MORF) United States $0.843B 0.00
Cellectis S.A (CLLS) France $0.836B 0.00
Codexis (CDXS) United States $0.832B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.821B 0.00
Alector (ALEC) United States $0.816B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.804B 0.00
Agenus (AGEN) United States $0.803B 0.00
Protagonist Therapeutics (PTGX) United States $0.766B 0.00
Frequency Therapeutics (FREQ) United States $0.743B 0.00
MiMedx (MDXG) United States $0.724B 0.00
Kadmon Holdings (KDMN) United States $0.685B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.678B 0.00
Pharming Group (PHGUF) Netherlands $0.670B 15.29
VBI Vaccines (VBIV) United States $0.666B 0.00
AnaptysBio (ANAB) United States $0.657B 0.00
Cara Therapeutics (CARA) United States $0.656B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Cel-Sci (CVM) United States $0.619B 0.00
Celldex Therapeutics (CLDX) United States $0.617B 0.00
Geron (GERN) United States $0.599B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.590B 5.16
ZIOPHARM Oncology Inc (ZIOP) United States $0.580B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.580B 0.00
IVERIC Bio (ISEE) United States $0.571B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.551B 0.00
Anika Therapeutics (ANIK) United States $0.548B 23.94
Clovis Oncology (CLVS) United States $0.529B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.520B 0.00
Albireo Pharma (ALBO) United States $0.519B 0.00
MeiraGTx Holdings (MGTX) United States $0.506B 0.00
Dynavax Technologies (DVAX) United States $0.486B 0.00
UROGEN PHARMA (URGN) United States $0.477B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.470B 0.00
Cue Biopharma (CUE) United States $0.463B 0.00
MannKind (MNKD) United States $0.458B 0.00
Prothena (PRTA) Ireland $0.454B 0.00
Avid Bioservices (CDMO) United States $0.453B 0.00
Kala Pharmaceuticals (KALA) United States $0.451B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.440B 0.00
Forte Biosciences (FBRX) United States $0.435B 0.00
Starpharma Holdings (SPHRY) Australia $0.428B 0.00
Amryt Pharma (AMYT) United Kingdom $0.428B 0.00
Scholar Rock Holding (SRRK) United States $0.424B 0.00
Sutro Biopharma (STRO) United States $0.424B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.395B 0.00
Puma Biotechnology (PBYI) United States $0.390B 0.00
Trevena (TRVN) United States $0.387B 0.00
Syros Pharmaceuticals (SYRS) United States $0.384B 0.00
Merus (MRUS) Netherlands $0.379B 0.00
BioDelivery Sciences (BDSI) United States $0.372B 26.36
IBio (IBIO) United States $0.370B 0.00
Athersys (ATHX) United States $0.369B 0.00
ANI Pharmaceuticals (ANIP) United States $0.367B 8.66
Aeglea BioTherapeutics (AGLE) United States $0.364B 0.00
Precision BioSciences (DTIL) United States $0.357B 0.00
Cellular Biomedicine (CBMG) United States $0.357B 0.00
Kamada (KMDA) Israel $0.354B 16.92
Cardiff Oncology (CRDF) United States $0.353B 0.00
AC Immune SA (ACIU) Switzerland $0.350B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.340B 0.00
Spero Therapeutics (SPRO) United States $0.335B 0.00
Innate Pharma S.A (IPHA) France $0.329B 0.00
WAVE Life Sciences (WVE) Singapore $0.325B 0.00
CytomX Therapeutics (CTMX) United States $0.317B 0.00
NextCure (NXTC) United States $0.313B 0.00
ChromaDex (CDXC) United States $0.308B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.308B 0.00
Pluristem Therapeutics (PSTI) Israel $0.273B 0.00
Affimed (AFMD) Germany $0.271B 0.00
Selecta Biosciences (SELB) United States $0.267B 0.00
PDL BioPharma (PDLI) United States $0.264B 0.00
Arbutus Biopharma (ABUS) United States $0.248B 0.00
Fortress Biotech (FBIO) United States $0.243B 0.00
XOMA (XOMA) United States $0.234B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.232B 0.00
TELA Bio (TELA) United States $0.231B 0.00
Verastem (VSTM) United States $0.222B 0.00
Five Prime Therapeutics (FPRX) United States $0.218B 0.00
HOOKIPA Pharma (HOOK) United States $0.213B 0.00
ADMA Biologics Inc (ADMA) United States $0.196B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.195B 0.00
Dyadic (DYAI) United States $0.190B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
DBV Technologies S.A (DBVT) France $0.183B 0.00
CorMedix Inc (CRMD) United States $0.181B 0.00
Cerecor (CERC) United States $0.181B 0.00
Aptinyx (APTX) United States $0.175B 0.00
Theratechnologies (THTX) Canada $0.175B 0.00
Prometic Life Sciences (LMNL) Canada $0.174B 0.00
Exicure (XCUR) United States $0.173B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.172B 0.00
VolitionRX (VNRX) United States $0.171B 0.00
Kindred Biosciences (KIN) United States $0.169B 0.00
Biofrontera AG (BFRA) Germany $0.168B 0.00
GENFIT S.A (GNFT) France $0.167B 0.00
Eton Pharmaceuticals (ETON) United States $0.162B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.158B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.157B 7.35
Checkpoint Therapeutics (CKPT) United States $0.156B 0.00
Nicox SA (NICXF) France $0.149B 0.00
Bellus Health (BLU) Canada $0.144B 0.00
AquaBounty Technologies (AQB) United States $0.142B 0.00
Catalyst Biosciences (CBIO) United States $0.141B 0.00
Applied Genetic Technologies (AGTC) United States $0.141B 0.00
SESEN BIO, INC (SESN) United States $0.132B 0.00
Cidara Therapeutics (CDTX) United States $0.132B 0.00
Aytu Bioscience (AYTU) United States $0.130B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.125B 0.00
VTv Therapeutics (VTVT) United States $0.122B 0.00
Strongbridge Biopharma (SBBP) United States $0.121B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.119B 0.00
Protalix BioTherapeutics (PLX) Israel $0.118B 0.00
Lumos Pharma (LUMO) United States $0.118B 0.00
Abeona Therapeutics (ABEO) United States $0.114B 0.00
Celyad SA (CYAD) Belgium $0.114B 0.00
Gritstone Oncology (GRTS) United States $0.112B 0.00
Oncobiologics (OTLK) United States $0.112B 0.00
Windtree Therapeutics (WINT) United States $0.111B 0.00
Orgenesis (ORGS) United States $0.109B 5.55
Unum Therapeutics (COGT) United States $0.109B 0.00
Liquidia Technologies (LQDA) United States $0.108B 0.00
Enzo Biochem (ENZ) United States $0.103B 0.00
Antibe Therapeutics (ATBPF) Canada $0.102B 0.00
AIT Therapeutics (XAIR) United States $0.101B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.101B 0.00
Palatin Technologies (PTN) United States $0.100B 0.00
Cyclerion Therapeutics (CYCN) United States $0.100B 0.00
Evogene (EVGN) Israel $0.098B 0.00
Ecology Coatings (ABVC) United States $0.087B 0.00
DiaMedica Therapeutics (DMAC) United States $0.086B 0.00
ARAVIVE, INC (ARAV) United States $0.082B 0.00
Idera Pharmaceuticals (IDRA) United States $0.080B 0.00
Bionano Genomics (BNGO) United States $0.079B 0.00
Stealth BioTherapeutics (MITO) United States $0.074B 71.00
Edesa Biotech (EDSA) Canada $0.072B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
Synlogic (SYBX) United States $0.069B 0.00
Curis (CRIS) United States $0.068B 0.00
Clearside Biomedical (CLSD) United States $0.068B 0.00
Adocia (ADOCY) France $0.067B 0.00
Appili Therapeutics (APLIF) Canada $0.066B 0.00
Prima BioMed (IMMP) Australia $0.066B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.066B 0.00
Proteostasis Therapeutics (PTI) United States $0.064B 0.00
Organovo Holdings (ONVO) United States $0.063B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.063B 0.00
AmpliPhi Biosciences (ARMP) United States $0.062B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.060B 0.00
TRACON Pharmaceuticals (TCON) United States $0.060B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.057B 0.00
Soligenix (SNGX) United States $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.051B 0.00
Genetic Technologies (GENE) Australia $0.048B 0.00
Cocrystal Pharma (COCP) United States $0.047B 0.00
Happiness Biotech Group (HAPP) China $0.044B 0.00
IMMURON (IMRN) Australia $0.043B 0.00
Novogen (KZIA) Australia $0.042B 0.00
CollPlant Holdings (CLGN) Israel $0.041B 0.00
Pulmatrix (PULM) United States $0.041B 0.00
Vaccinex (VCNX) United States $0.040B 0.00
AnPac Bio-Medical Science (ANPC) China $0.039B 0.00
Apricus Biosciences (SEEL) United States $0.039B 0.00
Chanticleer Holdings (SONN) United States $0.037B 0.00
ATyr Pharma (LIFE) United States $0.034B 0.00
OvaScience (MLND) United States $0.034B 0.00
Acorda Therapeutics (ACOR) United States $0.032B 0.00
Signal Genetics (MGEN) United States $0.031B 0.00
Cleveland BioLabs (CBLI) United States $0.030B 0.00
BioCardia (BCDA) United States $0.029B 0.00
Advaxis (ADXS) United States $0.027B 0.00
Prana Biotechnology (ATHE) Australia $0.027B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.025B 0.00
Alimera Sciences (ALIM) United States $0.024B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.023B 0.00
Aptevo Therapeutics (APVO) United States $0.023B 0.00
Celsion (CLSN) United States $0.023B 0.00
Spherix (AIKI) United States $0.020B 0.00
AEterna Zentaris (AEZS) United States $0.020B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.019B 0.00
Cesca Therapeutics (THMO) United States $0.019B 0.00
MYOS RENS Technology (MYOS) United States $0.016B 0.00
Titan Pharmaceuticals (TTNP) United States $0.014B 0.00
BioPharmX (TMBR) United States $0.013B 0.00
Neuralstem (SNCA) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
GeoVax Labs (GOVX) United States $0.002B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00